Your Health, We Care
Nintedanib is indicated for the treatment of idiopathic pulmonary fibrosis (IPF) in adults.
Nintedanib is indicated for the treatment of chronic fibrosing interstitial lung disease (ILDs) with a progressive phenotype in adults.
Nintedanib is indicated for slowing the rate of decline in lung function in adults with systemic sclerosis-associated interstitial lung disease (SSc-ILD).
FDA，2024.10
It is indicated for the treatment of idiopathic pulmonary fibrosis (IPF), chronic fibrosing interstitial lung disease (ILD), and systemic sclerosis-associated interstitial lung dis···【more】
Article source：Lucius LaosRelease date：2026-01-05Recommended：15
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
